Lataa...

Delayed rejection of MHC class II-disparate skin allografts in mice treated with farnesyltransferase inhibitors

Farnesyltransferase inhibitors (FTIs), developed as anti-cancer drugs, have the potential to modulate immune responses without causing nonspecific immune suppression. We have investigated the possibility that FTIs, by affecting T cell cytokine secretion, can attenuate alloreactive immune responses....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transpl Immunol
Päätekijät: Gaylo, Alison E., Laux, Kathleen S., Batzel, Erika J., Berg, Morgan E., Field, Kenneth A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2008
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7369389/
https://ncbi.nlm.nih.gov/pubmed/18930822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trim.2008.09.011
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!